Skip to content
R

Ripon Biswas

Publications (4)

Prevalence of Older Age Diabetes in Rural Area of North-West Region of Bangladesh

Ripon Biswas, Sazin Islam, Mosammat Sabrina Sibli, Deep Chowdhury, Oasim Ghosh, Sharmin Akter & Md. Shariful Islam · Asian Journal of Research and Reports in Endocrinology · 2022

Background: Bangladesh's north-west region consistently has worse health results than the rest of the nation. Many chronic illnesses, including diabetes, which is the seventh biggest cause of mortality in Bangladesh, fall under this category. This research compared the prevalence...

Open access Research Article

A Study on the Bangladeshi Mothers' Experiences with Intrauterine Fetal Death (IUFD)

Deep Chowdhury, Sazin Islam, Ripon Biswas, Agro Bhowmik Jyoti, Sonia Afroz Mukta & Md. Shariful Islam · Journal of Advances in Medicine and Medical Research · 2022

Background: IUFD (intrauterine fetal death/demise) is a devastating experience for moms. IUFD mothers run the danger of going through life feeling depressed, anxious, unhappy, and sorrowful. Therefore, it is essential to do research on how moms cope with such a terrible event. Pu...

Open access Research Article 10.9734/jammr/2022/v34i234870

An Analysis of Unwanted Births in Bangladesh: A Major Public Health Concern

Md. Jalal Uddin, Sazin Islam, Oasim Ghosh, Ripon Biswas, Mosammat Sabrina Sibli, Sharmin Akter & Md. Shariful Islam · International Journal of Research and Reports in Gynaecology · 2022

Background: In Bangladesh, on average, a woman has 2.3 births, with around 30% of them being undesired. For the well-being of families and the regulation of population growth, it is crucial to reduce unwanted births. In-depth study of the variables influencing the shift in unplan...

Open access Research Article

A Public Health Perspective on Sedation Dentistry in Bangladesh: Use of Clonidine

Oasim Ghosh, Sazin Islam, Md. Jalal Uddin, Deep Chowdhury, Ripon Biswas, Sharmin Akter & Md. Shariful Islam · International Journal of Research and Reports in Dentistry · 2022

Background: Since more than 40 years ago, people have been using the alpha-2 adrenergic agonist clonidine to treat hypertension. The FDA authorized the use of clonidine in October 2008 as a premedication drug before sedation. This study's main objective is to discover if clonidin...

Open access Research Article